These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 12833174

  • 1. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
    Stoika R, Yakymovych M, Souchelnytskyi S, Yakymovych I.
    Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin-resistant derivatives of murine L1210 leukemia cells are not susceptible to growth-inhibiting and apoptosis-inducing actions of transforming growth factor-beta1.
    Stoika RS, Yakymovych MYa, Yakymovych IA, Chekhun VF.
    Anticancer Drugs; 1999 Jun; 10(5):457-63. PubMed ID: 10477165
    [Abstract] [Full Text] [Related]

  • 3. Expression of bcl-2 and bax in TGF-beta 1-induced apoptosis of L1210 leukemic cells.
    Motyl T, Grzelkowska K, Zimowska W, Skierski J, Wareski P, Płoszaj T, Trzeciak L.
    Eur J Cell Biol; 1998 Apr; 75(4):367-74. PubMed ID: 9628323
    [Abstract] [Full Text] [Related]

  • 4. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL, Tran H, Karlan BY.
    Cancer Res; 2003 Mar 15; 63(6):1413-9. PubMed ID: 12649207
    [Abstract] [Full Text] [Related]

  • 5. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
    Gibalová L, Sereš M, Rusnák A, Ditte P, Labudová M, Uhrík B, Pastorek J, Sedlák J, Breier A, Sulová Z.
    Toxicol In Vitro; 2012 Apr 15; 26(3):435-44. PubMed ID: 22269388
    [Abstract] [Full Text] [Related]

  • 6. Expression of TGF-beta related Smad proteins in human epithelial skin tumors.
    Lange D, Persson U, Wollina U, ten Dijke P, Castelli E, Heldin CH, Funa K.
    Int J Oncol; 1999 Jun 15; 14(6):1049-56. PubMed ID: 10339656
    [Abstract] [Full Text] [Related]

  • 7. Transforming growth factor-beta 1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells.
    Francis JM, Heyworth CM, Spooncer E, Pierce A, Dexter TM, Whetton AD.
    J Biol Chem; 2000 Dec 15; 275(50):39137-45. PubMed ID: 10993901
    [Abstract] [Full Text] [Related]

  • 8. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity.
    Gibalová L, Sedlák J, Labudová M, Barancík M, Reháková A, Breier A, Sulová Z.
    Gen Physiol Biophys; 2009 Dec 15; 28(4):391-403. PubMed ID: 20097962
    [Abstract] [Full Text] [Related]

  • 9. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y, Kyprianou N.
    Cancer Res; 1999 Mar 15; 59(6):1366-71. PubMed ID: 10096572
    [Abstract] [Full Text] [Related]

  • 10. Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis.
    Yamamura Y, Hua X, Bergelson S, Lodish HF.
    J Biol Chem; 2000 Nov 17; 275(46):36295-302. PubMed ID: 10942775
    [Abstract] [Full Text] [Related]

  • 11. Association between endogenous gene expression and growth regulation induced by TGF-beta1 in human gastric cancer cells.
    Li X, Zhang YY, Wang Q, Fu SB.
    World J Gastroenterol; 2005 Jan 07; 11(1):61-8. PubMed ID: 15609398
    [Abstract] [Full Text] [Related]

  • 12. The induction of apoptosis by a combined 1,25(OH)2D3 analog, EB1089 and TGF-beta1 in NCI-H929 multiple myeloma cells.
    Park WH, Seol JG, Kim ES, Binderup L, Koeffler HP, Kim BK, Lee YY.
    Int J Oncol; 2002 Mar 07; 20(3):533-42. PubMed ID: 11836565
    [Abstract] [Full Text] [Related]

  • 13. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells.
    Chen YX, Wang Y, Fu CC, Diao F, Song LN, Li ZB, Yang R, Lu J.
    Endocr Relat Cancer; 2010 Mar 07; 17(1):39-50. PubMed ID: 19776289
    [Abstract] [Full Text] [Related]

  • 14. Deficient apoptotic process in cisplatin-resistant L1210 cells cannot account for the cellular response to various drug treatments.
    Canitrot Y, Frit P, Salles B.
    Biochem Biophys Res Commun; 1997 May 29; 234(3):573-7. PubMed ID: 9175754
    [Abstract] [Full Text] [Related]

  • 15. Effect of anticancer drugs on production of transforming growth factor and expression of p53 AND Bcl-2 proteins by MCF-7 and T47D cell lines of human breast carcinoma.
    Stoika RS, Yakymovych IA, Kashchak NI, Boyko MM, Korynevska AV, Klyuchyvska OY, Shafranska GI, Yakymovych MY, Zhylchuk VY, Kudryavets YY, Vorontsova AL.
    Exp Oncol; 2008 Mar 29; 30(1):35-41. PubMed ID: 18438339
    [Abstract] [Full Text] [Related]

  • 16. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S, Firth SM, Baxter RC.
    J Biol Chem; 2002 Mar 01; 277(9):7255-61. PubMed ID: 11751851
    [Abstract] [Full Text] [Related]

  • 17. Resistance to transforming growth factor-beta occurs in the presence of normal Smad activation.
    Berger DH, Feng XH, Yao J, Saha D, Beauchamp RD, Lin X.
    Surgery; 2002 Aug 01; 132(2):310-6. PubMed ID: 12219028
    [Abstract] [Full Text] [Related]

  • 18. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS.
    Oncogene; 2002 Feb 28; 21(10):1616-24. PubMed ID: 11896591
    [Abstract] [Full Text] [Related]

  • 19. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
    Wang H, Yang GH, Bu H, Zhou Q, Guo LX, Wang SL, Ye L.
    Int J Exp Pathol; 2003 Jun 28; 84(3):153-63. PubMed ID: 12974945
    [Abstract] [Full Text] [Related]

  • 20. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
    Fanayan S, Firth SM, Butt AJ, Baxter RC.
    J Biol Chem; 2000 Dec 15; 275(50):39146-51. PubMed ID: 10993898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.